| Literature DB >> 29034584 |
Michelle L Ratay1, Elena Bellotti2, Riccardo Gottardi3, Steven R Little4.
Abstract
Dry eye disease, age-related macular degeneration, and uveitis are ocular diseases that significantly affect the quality of life of millions of people each year. In these diseases, the action of chemokines, proinflammatory cytokines, and immune cells drives a local inflammatory response that results in ocular tissue damage. Multiple therapeutic strategies are developed to either address the symptoms or abate the underlying cause of these diseases. Herein, the challenges to deliver drugs to the relevant location in the eye for each of these diseases are reviewed along with current and innovative therapeutic approaches that attempt to restore homeostasis within the ocular microenvironment.Entities:
Keywords: age-related macular degeneration; drug delivery; dry eye disease; therapeutics; uveitis
Mesh:
Substances:
Year: 2017 PMID: 29034584 PMCID: PMC5915344 DOI: 10.1002/adhm.201700733
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933